Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5736577A · kind A · utility
30Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 1996 |
| Grant date | Apr 7, 1998 |
| Priority date | — |
| Expiry date | Jun 28, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin, or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer. Pharmaceutical compositions comprising (S)-oxybutynin, or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer, and a pharmaceutically acceptable carrier are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.